Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
ACS Chemical Biology|June 20, 2022
Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-CoronavirusesXuan Yang, Rebekah J Dickmander, Armin Bayati, et al.
Journal of Medicinal Chemistry|July 3, 2024
More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5-<i>a</i>]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus ReplicationHan Wee Ong, Xuan Yang, Jeffery L Smith, et al.
Biorxiv : the Preprint Server for Biology|May 10, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAMFrances M Bashore, Vittorio L Katis, Yuhong Du, et al.
Elife|July 25, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Plos One|February 15, 2024
Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAMFrances M Bashore, Vittorio L Katis, Yuhong Du, et al.
Plos One|August 3, 2017
Progress towards a public chemogenomic set for protein kinases and a call for contributionsDavid H Drewry, Carrow I Wells, David M Andrews, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
PAK1 inhibitor NVS-PAK1-1 preserves dendritic spines in amyloid/tau exposed neurons and 5xFAD miceTao Yang, Hasi Huhe, Sean-Paul Williams, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discoveryFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Pageof 7